Arkolith/Insider Trading/TCRX/Form 4

Nichols Weston

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Dec 30, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 26, 2024Buy(P)7.5M$4.00$30.0M7.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-24-007064) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML